Medical Marijuana Inc (OTCMKTS:MJNA), as we have recently noted, is one of the more interesting stories in the MMJ space right now in terms of its recent emphasis on developing the roots of expansion into Central and South America. In a recent release, the company notes that its subsidiary HempMeds Brasil has begun the process of importing its Real Scientific Hemp Oil (RSHO) Green Label into Brazil.
The communication goes on to highlight that HempMeds Brasil is “the first company to offer legal medical cannabis products to Brazil after receiving approval to import to those suffering from specific medical conditions. RSHO™ is a natural, full-spectrum CBD oil extracted from hemp plants grown in Northern Europe. The RSHO™ Green Label contains a high concentration of cannabinoids in their acidic form – Cannabidiolic Acid. This product is an integral “juice” or extract of the plant that HempMeds ® grows.” This sets MJNA apart from its domestically focused competition on at least the geographic element, which implied a degree of legislative diversification that could be important in a dynamic political context.
Medical Marijuana Inc (OTCMKTS:MJNA) trumpets itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.
The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.
In addition, MJNA provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products.
Medical Marijuana Inc. is the first publicly held company vested in the medical marijuana and industrial hemp markets.
According to company materials, “The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid delivery methods that are more socially and medically acceptable than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.”
Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March 2011. The company was incorporated in 2003 and is headquartered in Poway, California.
Find out when $MJNA stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
“We are proud to announce the import of RSHO™ Green Label to the people of Brazil,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “The introduction of this product in Brazil signals a huge step forward for those in need of medicinal relief and those who continue to suffer at the hands of inadequate restorative aid. Our company has, and will, continue to be driven by the idea that the interests of people come before profit models. From athletes, to around-the-clock business owners, to children as well as the elderly, we see the potential for an overwhelmingly positive affect on the lives of millions within the country. I am firmly confident in the potential and future of our product within the country of Brazil.”
The stock has been a bit stagnant of late, with only about 8% in upside during the past month. However, that is certainly better than movement in the opposite direction. Volume has been rising a bit in the past couple weeks, suggesting some new money getting involved as well (8% above average volume levels).
Currently trading at a market capitalization of $485.3M, MJNA has a stash ($406K) of cash on the books, which is balanced by about $3.9M in total current liabilities. So, this is far from a sterling balance sheet situation. And that debt has been growing over recent quarters.
That said, MJNA is pulling in trailing 12-month revenues of $7M. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 18.6%. Additionally, the recent developments with HempMeds make this a very interesting story and we will look forward to updating it again soon. For continuing coverage on shares of $MJNA stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!